IMUX
Income statement / Annual
Last year (2023), Immunic, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Immunic, Inc.'s net income was -$93.61 M.
See Immunic, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$6,315.12
|
$0.00
|
$0.00
|
| Cost of Revenue |
$111,000.00 |
$77,000.00 |
$85,000.00 |
$39,000.00 |
$50,000.00 |
$15,000.00 |
$998,000.00 |
$1.81 M |
$1.33 M |
$0.00 |
| Gross Profit |
-$111,000.00 |
-$77,000.00 |
-$85,000.00 |
-$39,000.00 |
-$50,000.00 |
-$15,000.00 |
-$998,000.00 |
-$1.80 M |
-$1.33 M |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-285.3 |
0 |
0 |
| Research and Development
Expenses |
$83.22 M
|
$71.26 M
|
$61.12 M
|
$38.64 M
|
$22.51 M
|
$24.83 M
|
$39.34 M
|
$30.05 M
|
$39.77 M
|
$39.48 M
|
| General & Administrative
Expenses |
$16.01 M
|
$15.26 M
|
$13.30 M
|
$10.33 M
|
$14.52 M
|
$13.59 M
|
$13.31 M
|
$11.22 M
|
$12.35 M
|
$10.86 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$16.01 M
|
$15.26 M
|
$13.30 M
|
$10.33 M
|
$14.52 M
|
$13.59 M
|
$13.31 M
|
$11.22 M
|
$12.35 M
|
$10.86 M
|
| Other Expenses |
$0.00 |
-$1.96 M |
$17.25 M |
$4.90 M |
$1.99 M |
$28,000.00 |
$0.00 |
$297,000.00 |
$97,000.00 |
$2.68 M |
| Operating Expenses |
$99.22 M |
$86.52 M |
$91.67 M |
$48.97 M |
$37.03 M |
$38.41 M |
$52.66 M |
$41.27 M |
$52.12 M |
$50.34 M |
| Cost And Expenses |
$99.22 M |
$86.52 M |
$91.67 M |
$48.97 M |
$37.03 M |
$38.41 M |
$52.66 M |
$41.27 M |
$52.12 M |
$50.34 M |
| Interest Income |
$3.08 M |
$1.04 M |
$66,000.00 |
$58,000.00 |
$107,000.00 |
$521,000.00 |
$650,000.00 |
$284,000.00 |
$58,000.00 |
$19,000.00 |
| Interest Expense |
$0.00 |
$1.04 M |
$0.00 |
$0.00 |
$107,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$111,000.00
|
$77,000.00
|
$85,000.00
|
$39,000.00
|
$50,000.00
|
$15,000.00
|
$998,000.00
|
$1.81 M
|
$1.33 M
|
$1.09 M
|
| EBITDA |
-$99.11 M
|
-$120.33 M
|
-$92.86 M
|
-$48.93 M
|
-$36.98 M
|
-$15.14 M
|
-$51.08 M
|
-$39.16 M
|
-$50.70 M
|
-$46.58 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-6534.48 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-6534.48
|
0
|
0
|
| Total Other
Income/Expenses Net |
$5.61 M
|
-$919,000.00
|
-$1.28 M
|
$4.95 M
|
$2.10 M
|
$455,000.00
|
$577,000.00
|
$297,000.00
|
$97,000.00
|
$2.68 M
|
| Income Before Tax |
-$93.61 M |
-$120.41 M |
-$92.95 M |
-$44.02 M |
-$34.93 M |
-$41.48 M |
-$52.08 M |
-$40.97 M |
-$52.02 M |
-$47.67 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-6487.45
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$33.89 M |
-$151,000.00 |
-$58,000.00 |
-$107,000.00 |
$549,000.00 |
-$577,000.00 |
-$1.81 M |
-$1.33 M |
-$1.09 M |
| Net Income |
-$93.61 M |
-$154.30 M |
-$92.79 M |
-$43.96 M |
-$34.83 M |
-$41.48 M |
-$52.08 M |
-$40.97 M |
-$52.02 M |
-$47.67 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-6487.45 |
0 |
0 |
| EPS |
-2.11 |
-4.85 |
-3.92 |
-2.81 |
-4.51 |
-39.16 |
-52.26 |
-52.21 |
-82.73 |
-80.01 |
| EPS Diluted |
-2.11 |
-4.85 |
-3.92 |
-2.81 |
-4.51 |
-39.16 |
-52.26 |
-52.21 |
-82.73 |
-80.01 |
| Weighted Average Shares
Out |
$44.32 M
|
$31.82 M
|
$23.65 M
|
$15.66 M
|
$7.72 M
|
$1.06 M
|
$996,475.00
|
$784,689.00
|
$628,823.00
|
$595,777.00
|
| Weighted Average Shares
Out Diluted |
$44.32 M
|
$31.82 M
|
$23.65 M
|
$15.66 M
|
$7.72 M
|
$1.06 M
|
$996,475.00
|
$784,689.00
|
$628,823.00
|
$595,777.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
